Chattem's CHTT second-quarter results were in line with our expectations, so our fair value estimate for the shares remains unchanged. The firm is already reaping the benefits of the five brands it acquired from Johnson & Johnson JNJ in early January in the form of sales growth and improving ...
Medicated Skin Care Products - Global Strategic Business Report 2016-2022: Increasing Focus on Wellness and Self-Care amidst Mounting Healthcare Costs Drive Healthy Market Growth - Research and Markets
These great businesses are undervalued and run by CEOs that are looking out for the best interests of shareholders.
We believe breakups could unlock value for big pharma shareholders.